A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Hoffmann, Markus, Kleine-Weber, Hannah, Pöhlmann, Stefan·2020·Molecular Cell
DOI 10.1016/j.molcel.2020.04.022

Cited by (1,004)

Items 201–300 of 1,004

  1. Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation
    Mart Matthias Lamers, Anna Z. Mykytyn, Tim I. Breugem, Yiquan Wang, Douglas C. Wu, Samra Riesebosch, Petra B. van den Doel, Debby Schipper, Theo M. Bestebroer, Nicholas C. Wu et al. · 2021 · eLife
  2. COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
    Marek Ostaszewski, Anna Niarakis, Alexander Mazein, Inna Kuperstein, Robert D. Phair, Aurelio Orta Resendiz, Vidisha Singh, Sara Sadat Aghamiri, Márcio Luís Acencio, Enrico Glaab et al. · 2021 · Molecular Systems Biology
  3. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases
    Giovanni Arturo Rossi, Oliviero Sacco, Enrica Mancino, Luca Cristiani, Fabio Midulla · 2020 · Infection
  4. Rapid and Parallel Adaptive Mutations in Spike S1 Drive Clade Success in SARS-CoV-2
    Kathryn E. Kistler, John Huddleston, Trevor Bedford · 2021 · Cell Host & Microbe
  5. Viral Membrane Fusion: A Dance Between Proteins and Lipids
    Judith M. White, Amanda E. Ward, Laura Odongo, Lukas K. Tamm · 2023 · Annual Review of Virology
  6. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms
    Giulia Paiardi, Stefan Richter, Pasqua Oreste, Chiara Urbinati, Marco Rusnati, Rebecca C. Wade · 2021 · Journal of Biological Chemistry
  7. Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
    Magda Gioia, Chiara Ciaccio, Paolo A. Calligari, Giovanna De Simone, Diego Sbardella, Grazia Raffaella Tundo, Giovanni Francesco Fasciglione, Alessandra di Masi, Donato Di Pierro, Alessio Bocedi et al. · 2020 · Biochemical Pharmacology
  8. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
    Takehiro Ura, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada · 2020 · Vaccine
  9. SARS-CoV-2 and the Host Cell: A Tale of Interactions
    Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, Davide Finozzi, Carmelo Gentile, Michele Domenico Gentile, Roberta Marconi, Dalila Paladino, Alberto Raoss, Ilary Riedmiller et al. · 2022 · Frontiers in Virology
  10. Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases
    Yin Yao, Hai Wang, Zheng Liu · 2020 · Clinical & Experimental Allergy
  11. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
    Anastassios C. Papageorgiou, Imran Mohsin · 2020 · Cells
  12. Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS‐CoV‐2 Spike Protein**
    Deborah K. Shoemark, Charlotte K. Colenso, Christine Toelzer, Kapil Gupta, Richard Barry Sessions, Andrew D. Davidson, Imre Berger, Christiane Schaffitzel, JAMES M. SPENCER, Adrian John Mulholland · 2021 · Angewandte Chemie International Edition
  13. The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus
    Heather Wells, Michael C. Letko, Gorka Lasso, Benard Ssebide, Julius Nziza, Denis Karuhize Byarugaba, Isamara Navarrete‐Macias, E Liang, Michael R. Cranfield, Barbara A. Han et al. · 2021 · Virus Evolution
  14. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
    Scott B. Biering, Francielle Tramontini Gomes de Sousa, Laurentia V. Tjang, Felix Pahmeier, Chi Zhu, Richard Ruan, Sophie F. Blanc, Trishna S. Patel, Caroline M. Worthington, Dustin R. Glasner et al. · 2022 · Nature Communications
  15. ACE2, TMPRSS2, and Furin variants and SARS‐CoV‐2 infection in Madrid, Spain
    Laura Torre‐Fuentes, Jorge Matías‐Guiu, Laura Hernández‐Lorenzo, Paloma Montero‐Escribano, Vanesa Pytel, Jesús Porta-Etessam, Ulises Gómez‐Pinedo, Jordi A. Matías‐Guiu · 2020 · Journal of Medical Virology
  16. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein
    Cody B. Jackson, Lizhou Zhang, Michael Farzan, Hyeryun Choe · 2020 · Biochemical and Biophysical Research Communications
  17. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections
    Adivitiya, Manish Singh Kaushik, Soura Chakraborty, Shobi Veleri, Suneel Kateriya · 2021 · Biology
  18. HIV-1 infection activates endogenous retroviral promoters regulating antiviral gene expression
    Smitha Srinivasachar Badarinarayan, Irina Shcherbakova, Simon Langer, Lennart Koepke, Andrea Preising, Dominik Hotter, Frank Kirchhoff, Konstantin M. J. Sparrer, Gunnar Schotta, Daniel Sauter · 2020 · Nucleic Acids Research
  19. Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
    Qizhong Lu, Zongliang Zhang, Hexian Li, Kunhong Zhong, Qin Zhao, Zeng Wang, Zhiguo Wu, Donghui Yang, Shuang Sun, Nian Yang et al. · 2021 · Journal of Nanobiotechnology
  20. Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike
    Juliane Brun, Snežana Vasiljević, Bevin Gangadharan, Mario Hensen, Anu V. Chandran, Michelle L. Hill, J. L. Kiappes, Raymond Allen Dwek, Dominic S. Alonzi, Weston B. Struwe et al. · 2021 · ACS Central Science
  21. A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors
    A. Sofia F. Oliveira, Amaurys Ávila Ibarra, Isabel Bermúdez, Lorenzo Casalino, Zied Gaieb, Deborah K. Shoemark, Timothy C. Gallagher, Richard Barry Sessions, Rommie E. Amaro, Adrian John Mulholland · 2021 · Biophysical Journal
  22. Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication
    Santseharay Ramírez, Carlota Fernandez-Antunez, Andrea Galli, Alexander P. Underwood, Long V. Pham, Line Abildgaard Ryberg, Shan Feng, Martin Schou Pedersen, Lotte S. Mikkelsen, Sandrine Belouzard et al. · 2021 · Antimicrobial Agents and Chemotherapy
  23. The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
    Damien A. Leach, Andrea Mohr, Efstathios S. Giotis, Emine Cil, A. M. Isac, Laura L. Yates, William Barclay, Ralf Michael Zwacka, Charlotte Lynne Bevan, Greg Nicholas Brooke · 2021 · Nature Communications
  24. Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
    Liyan Guo, Sheng Lin, Zimin Chen, Yu Cao, Bin He, Guangwen Lu · 2023 · Signal Transduction and Targeted Therapy
  25. Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
    Hanh T. Nguyen, Shijian Zhang, Qian Wang, Saumya Anang, Jia Wang, Haitao Ding, John C. Kappes, Joseph Sodroski · 2020 · Journal of Virology
  26. ACE2-Independent Alternative Receptors for SARS-CoV-2
    Suhyeon Lim, Monica Zhang, Theresa Li-Yun Chang · 2022 · Viruses
  27. COVID-19 drug discovery and treatment options
    Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, Siddharth Sridhar, Kwok‐Yung Yuen · 2024 · Nature Reviews Microbiology
  28. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases
    To Sing Fung, Ding Xiang Liu · 2021 · Annual Review of Microbiology
  29. Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
    Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, Matthew C. Chan, Kui K. Chan, Timothy M. Fan, Keith L. Bailey, Matthew O. Lindeblad, Laura M. Cooper, Lijun Rong et al. · 2022 · Nature Chemical Biology
  30. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
    Paul Bastard, Sara E. Vazquez, Jamin Liu, Matthew T. Laurie, Chung‐Yu Wang, Adrian Gervais, Tom Le Voyer, Lucy Bizien, Colin R. Zamecnik, Quentin Philippot et al. · 2022 · Science Immunology
  31. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
    Mai Kishimoto, Kentaro Uemura, Takao Sanaki, Akihiko Sato, William W. Hall, Hiroaki Kariwa, Yasuko Orba, Hirofumi Sawa, Michihito Sasaki · 2021 · Viruses
  32. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D
    Ming-Yieh Peng, Wen-Chih Liu, Jing-Quan Zheng, Chien‐Lin Lu, Yi‐Chou Hou, Cai‐Mei Zheng, Jenn-Yeu Song, Kuo‐Cheng Lu, You‐Chen Chao · 2021 · International Journal of Molecular Sciences
  33. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis
    Natalia G. Herrera, Nicholas C. Morano, Alev Celikgil, George Ivanov Georgiev, Ryan J. Malonis, James H. Lee, Karen Tong, Olivia Vergnolle, Aldo B. Massimi, Laura Y. Yen et al. · 2020 · ACS Omega
  34. An update of anti-viral treatment of COVID-19
    Serap Şimşek Yavuz, Ipek Komsuoglu Celikyurt · 2021 · TURKISH JOURNAL OF MEDICAL SCIENCES
  35. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
    Peiran Chen, Mandi Wu, Yaqing He, Bing‐Hua Jiang, Ming‐Liang He · 2023 · Signal Transduction and Targeted Therapy
  36. Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
    Kalnin, Kirill V., Plitnik, Timothy, Kishko, Michael, Zhang, Jinrong, Zhang, Donghui, Beauvais, Adrien, Anosova, Natalie G., Tibbitts, Tim, DiNapoli, Josh, Ulinski, Gregory et al. · 2021 · npj Vaccines
  37. Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
    Fatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, Michael Schotsaert, Lynda Coughlan, Adolfo García‐Sastre, Florian Krammer · 2021 · mBio
  38. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
    Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lü, Ming Wang, Lin Zhu et al. · 2022 · Signal Transduction and Targeted Therapy
  39. Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
    Valeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, Dietmar Hammerschmid, Katie J. Doores, Richard T. Bradshaw, Ricardo B. Parsons, Donald J. Benton, Chloë Roustan, Eamonn Reading et al. · 2023 · Nature Communications
  40. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin
    Lynda J. Partridge, Lucy Urwin, Martin J.H. Nicklin, David C. James, Luke R. Green, Peter N. Monk · 2021 · Cells
  41. SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
    John E. Bowen, Young‐Jun Park, Cameron Stewart, Jack T Brown, William K. Sharkey, Alexandra C. Walls, Anshu Joshi, Kaitlin R. Sprouse, Matthew McCallum, M. Alejandra Tortorici et al. · 2022 · Science Immunology
  42. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance
    María José Lista, Helena Winstone, Harry Wilson, A. Stephens Dyer, Suzanne Pickering, Rui Pedro Galão, Giuditta De Lorenzo, Vanessa M. Cowton, Wilhelm Furnon, Nicolás M. Suárez et al. · 2022 · Journal of Virology
  43. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
    Ann-Kathrin Reuschl, Lucy G. Thorne, M. Whelan, Roberta Ragazzini, Wilhelm Furnon, Vanessa M. Cowton, G. De Lorenzo, Dejan Mesner, Jane Turner, Giulia Dowgier et al. · 2023 · bioRxiv
  44. The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin
    Thomas P. Peacock, Carol Sheppard, Jonathan C. Brown, Niluka Goonawardane, Jie Zhou, Max Whiteley, Thushan I. de Silva, William Barclay · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
    Abayasingam, Arunasingam, Balachandran, Harikrishnan, Agapiou, David, Hammoud, Mohamed, Rodrigo, Chaturaka, Keoshkerian, Elizabeth, Li, Hui, Brasher, Nicholas A., Christ, Daniel, Rouet, Romain et al. · 2021 · Cell Reports Medicine
  46. ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal–Oral Routes
    Mei Zhong, Bingpeng Lin, Janak Lal. Pathak, Hongbin Gao, Andrew J. Young, Xinhong Wang, Chang Liu, Kaibin Wu, Mingxiao Liu, Jian-ming Chen et al. · 2020 · Frontiers in Medicine
  47. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
    John Charles Rotondo, Fernanda Martini, Martina Maritati, Chiara Mazziotta, Giulia Di Mauro, Carmen Lanzillotti, Nicole Barp, Altea Gallerani, Mauro G. Tognon, Carlo Contini · 2021 · Viruses
  48. An engineered bispecific human monoclonal antibody against SARS-CoV-2
    Zhaohui Li, Shihua Li, Gen Zhang, Weiyu Peng, Zhen Chang, Xue Zhang, Zheng Fan, Yan Chai, Feiran Wang, Xin Zhao et al. · 2022 · Nature Immunology
  49. COVID-19 endocrinopathy with hindsight from SARS
    Kothandaraman Narasimhan, Rengaraj Anantharaj, Bo Xue, Wen Shan Yew, S. Sendhil Velan, Neerja Karnani, Melvin Khee‐Shing Leow · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  50. Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane
    Yeol Kyo Choi, Yiwei Cao, Martin Frank, Hyeonuk Woo, Sang‐Jun Park, Min Sun Yeom, Tristan Ian Croll, Chaok Seok, Wonpil Im · 2021 · Journal of Chemical Theory and Computation
  51. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19
    Immacolata Andolfo, Roberta Russo, Vito Alessandro Lasorsa, Sueva Cantalupo, Barbara Eleni Rosato, Ferdinando Bonfiglio, Giulia Frisso, Pasquale Abete, Gian Marco Cassese, Giuseppe Servillo et al. · 2021 · iScience
  52. The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment
    Lukas Wettstein, Frank Kirchhoff, Jan Münch · 2022 · International Journal of Molecular Sciences
  53. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
    Ziwei Yang, Yang Han, Shilei Ding, Wei Shi, Tongqing Zhou, Andrés Finzi, Peter D. Kwong, Walther Mothes, Maolin Lu · 2022 · mBio
  54. Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
    Nicholas K. Hurlburt, Leah J. Homad, Irika R. Sinha, Madeleine F. Jennewein, Anna J. MacCamy, Yu-Hsin Wan, Jim B. Boonyaratanakornkit, Anton M. Sholukh, Abigail M. Jackson, Pan-Pan Zhou et al. · 2022 · Communications Biology
  55. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
    Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, Yuanchen Liu, Yue Chai, Jialu Shi, Huiping Shuai, Yuxin Hou, Xiner Huang, Terrence Tsz‐Tai Yuen et al. · 2022 · Emerging Microbes & Infections
  56. Amino acid metabolism and signalling pathways: potential targets in the control of infection and immunity
    Daniel Tomé · 2021 · Nutrition and Diabetes
  57. Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom
    Ann Sarah Walker, Karina-Doris Vihta, Owen Gethings, Emma Pritchard, Joel W. Jones, Thomas House, Iain Bell, John I. Bell, John N Newton, Jeremy Farrar et al. · 2021 · New England Journal of Medicine
  58. Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor
    Rafał Butowt, Katarzyna Bilińska, Christopher S. von Bartheld · 2020 · ACS Chemical Neuroscience
  59. Regulatory T cells in COVID-19
    Huan Wang, Zhao Wang, Wen Cao, Qianqian Wu, Yujia Yuan, Xiangjian Zhang · 2021 · Aging and Disease
  60. Approaches towards fighting the COVID‑19 pandemic (Review)
    Shih‐Chang Tsai, Chi‐Cheng Lu, DA-TIAN BAU, Yu‐Jen Chiu, Yu‐Ting Yen, Yuan‐Man Hsu, Chih‐Wei Fu, Sheng‐Chu Kuo, Yu‐Shiang Lo, Hong‐Yi Chiu et al. · 2020 · International Journal of Molecular Medicine
  61. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry
    Shiyou Zhu, Ying Liu, Zhuo Long Zhou, Zhiying Zhang, Xia Xiao, Zhiheng Liu, Ang Chen, Xiaojing Dong, Feng Tian, Shihua Chen et al. · 2021 · Science China Life Sciences
  62. Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions
    Gytis Dudas, Samuel Leandro Hong, Barney I. Potter, Sébastien Calvignac‐Spencer, Frédéric S. Niatou-Singa, Thais B. Tombolomako, Terence Fuh Neba, Ulrich Vickos, Markus Ulrich, Fabian Hubertus Leendertz et al. · 2021 · Nature Communications
  63. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity
    Zhuanchang Wu, Zhaoying Zhang, Xin Wang, Jing Zhang, Caiyue Ren, Yuming Li, Lifen Gao, Xiaohong Liang, Pei‐Hui Wang, Chunhong Ma · 2021 · Signal Transduction and Targeted Therapy
  64. Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
    Qi Xiang, Linhao Li, Jie Wu, Miao Tian, Yang Fu · 2022 · Microbiological Research
  65. The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2
    Yujia A. Chan, Shing H. Zhan · 2021 · Molecular Biology and Evolution
  66. Potential Detrimental Role of Soluble ACE2 in Severe COVID-19 Comorbid Patients
    Mahmudur Rahman, Maruf Hasan, Asif Ahmed · 2020 · Reviews in Medical Virology
  67. SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
    Avaniyapuram Kannan Murugan, Ali Saeed Alzahrani · 2021 · Journal of Inflammation Research
  68. Zoonotic and reverse zoonotic events of SARS-CoV-2 and their impact on global health
    Khalid Munir, Shoaib Ashraf, Isra Munir, Hamna Khalid, Mohammad Akram Muneer, Noreen Mukhtar, Shahid Amin, Sohaib Ashraf, Muhammad Ahmad Imran, Umer Naveed Chaudhry et al. · 2020 · Emerging Microbes & Infections
  69. Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
    Stanislav Kurpe, Sergei Yu. Grishin, Alexey K. Surin, Alexander V. Panfilov, Mikhail V. Slizen, Saikat Dutta Chowdhury, Oxana V. Galzitskaya · 2020 · International Journal of Molecular Sciences
  70. Genetic and epigenetic factors associated with increased severity of Covid‐19
    Zafer Yildirim, Oyku Semahat Sahin, Seyhan Yazar, Vildan Bozok Çetintaş · 2021 · Cell Biology International
  71. Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza
    Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed, Mohammadreza Ardalan · 2021 · Frontiers in Molecular Biosciences
  72. SARS-CoV-2: A Master of Immune Evasion
    Alberto Rubio‐Casillas, Elrashdy M Moustafa Mohamed Redwan, Vladimir Nikolaevich Uversky · 2022 · Biomedicines
  73. Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
    Xinyu Li, Huijun Yuan, Xiaozhen Li, Hongliang Wang · 2022 · Journal of Medical Virology
  74. N-Acetylcysteine as a Potential Treatment for COVID-19
    Jorge Aarón Rangel-Méndez, Rosa Esther Moo-Puc · 2020 · Future Microbiology
  75. Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection
    Omid Tavassoly, Farinaz Safavi, Iman Tavassoly · 2020 · ACS Chemical Neuroscience
  76. An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic
    Sudhir Kumar, Qiqing Tao, Steven Weaver, Maxwell D. Sanderford, Marcos A. Caraballo‐Ortiz, Sudip Sharma, Sergei L. Kosakovsky Pond, Sayaka Miura · 2021 · Molecular Biology and Evolution
  77. Amino acid metabolism and signalling pathways: potential targets in the control of infection and immunity
    Daniel Tomé · 2021 · European Journal of Clinical Nutrition
  78. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart
    Hanna Bräuninger, Bastian Stoffers, Antonia Fitzek, Kira Meißner, Ganna Aleshcheva, Michaela Schweizer, Jessica Weimann, Björn Rotter, Svenja Warnke, Carolin Edler et al. · 2021 · Cardiovascular Research
  79. Arginine depletion as a therapeutic approach for patients with COVID-19
    Joseph M. Grimes, Shaheer A. Khan, Mark D. Badeaux, Ravi M. Rao, Scott W. Rowlinson, Richard D. Carvajal · 2020 · International Journal of Infectious Diseases
  80. Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2
    Zhenlu Li, Matthias Buck · 2021 · Biophysical Journal
  81. COVID-19 Mechanisms in the Human Body—What We Know So Far
    Ashutosh Kumar, Ravi Kant Narayan, Pranav Prasoon, Chiman Kumari, Gurjot Kaur, Santosh Kumar, Maheswari Kulandhasamy, Kishore Sesham, Vikas Pareek, Muneeb A. Faiq et al. · 2021 · Frontiers in Immunology
  82. Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
    Jonathan C. Brown, Daniel H. Goldhill, Jie Zhou, Thomas P. Peacock, Rebecca Frise, Niluka Goonawardane, Laury Baillon, Ruthiran Kugathasan, Andreia Pinto, Paul F. McKay et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
    Li, Xue, Zhang, Ziqi, Wang, Zhenling, Gutiérrez-Castrellón, Pedro, Shi, Huashan · 2022 · Signal Transduction and Targeted Therapy
  84. Novel compounds targeting neuropilin receptor 1 with potential to interfere with SARS-CoV-2 virus entry
    S. Perez-Miller, M. Patek, Aubin Moutal, Paz Duran, C. R. Cabel, C. Thorne, S. K. Campos, R. Khanna · 2021 · ACS Chemical Neuroscience
  85. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
    Enya Qing, Tom Kicmal, Binod Kumar, Grant M. Hawkins, Emily C. Timm, Stanley M. Perlman, Tom Gallagher · 2021 · mBio
  86. Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
    Senem Merve Fred, Suvi H. Kuivanen, Hasan Uğurlu, Plinio Cabrera Casarotto, Lev Levanov, Kalle Saksela, Olli P. Vapalahti, Eero Ċastrén · 2022 · Frontiers in Pharmacology
  87. The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi
    Louisa Chan, Danielle E. Anderson, Hong Sheng Cheng, Fransiskus Xaverius Ivan, Si Chen, Adrian Kang Eng Zheng, Randy Foo, Akshamal Mihiranga Gamage, Pei Yee Tiew, Mariko Siyue Koh et al. · 2022 · Nature Communications
  88. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications
    Bálint Mészáros, Hugo Sámano‐Sánchez, Jesús Alvarado-Valverde, Jelena Čalyševa, Elizabeth Martínez‐Pérez, Renato Alves, Denis C. Shields, Manjeet Kumar, Friedrich Rippmann, Lucia Beatriz Chemes et al. · 2021 · Science Signaling
  89. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection
    Andrey V. Letarov, Vladislav V. Babenko, Eugene E. Kulikov · 2020 · Biochemistry (Moscow)
  90. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
    Anna Maria Fratta Pasini, Chiara Stranieri, Luciano Cominacini, Chiara Mozzini · 2021 · Antioxidants
  91. Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry
    Lohra M. Miller, Lauren F. Barnes, Shannon A. Raab, Benjamin E. Draper, Tarick J. El‐Baba, Corinne A. Lutomski, Carol V. Robinson, David E. Clemmer, Martin F. Jarrold · 2021 · Journal of the American Chemical Society
  92. Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization
    Relja V. Suručić, Biljana Tubić, Miloš P. Stojiljković, Dragan M. Djuric, Maja Travar, Milkica Grabež, Katarina Šavikin, Ranko Škrbić · 2020 · Molecular and Cellular Biochemistry
  93. T-cell dysregulation in COVID-19
    Bahire Kalfaoglu, José Almeida‐Santos, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono · 2020 · Biochemical and Biophysical Research Communications
  94. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition
    Chanakha K. Navaratnarajah, David Randall Pease, Peter Halfmann, Biruhalem Taye, Alison J. Barkhymer, Kyle G. Howell, Jon E. Charlesworth, Trace A. Christensen, Yoshihiro Kawaoka, Roberto Cattaneo et al. · 2021 · Journal of Virology
  95. Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway
    Zhou, Jie, Peacock, Thomas P., Brown, Jonathan C., Goldhill, Daniel H., Elrefaey, Ahmed M.E., Penrice-Randal, Rebekah, Cowton, Vanessa M., De Lorenzo, Giuditta, Furnon, Wilhelm, Harvey, William T. et al. · 2022 · Cell Reports
  96. Structural and functional modelling of SARS-CoV-2 entry in animal models
    Greg Nicholas Brooke, Filippo Prischi · 2020 · Scientific Reports
  97. SARS-CoV-2, an Underestimated Pathogen of the Nervous System
    Shweta Jakhmola, Omkar Indari, Sayantani Chatterjee, Hem Chandra Jha · 2020 · SN Comprehensive Clinical Medicine
  98. Viral infection and smell loss: The case of COVID‐19
    Isaías Glezer, Alexandre Bruni‐Cardoso, Deborah Schechtman, Bettina Malnic · 2020 · Journal of Neurochemistry
  99. Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)
    Silvia Vivarelli, Luca Falzone, Francesco Torino, Giuseppa Scandurra, Giulia Lo Russo, Roberto Bordonaro, Francesco Pappalardo, Demetrios A. Spandidos, Giuseppina Raciti, Massimo Libra · 2020 · International Journal of Oncology
  100. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket
    Lucy Fallon, Kellon A. A. Belfon, Lauren E. Raguette, Yuzhang Wang, Darya Stepanenko, Abbigayle E. Cuomo, Jose Guerra, Stephanie Budhan, Sarah Varghese, Christopher P. Corbo et al. · 2021 · Journal of the American Chemical Society